Human CXCL14/BRAK ELISA Kit (Chemiluminescence)
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-70018
Key Product Details
Sample Type & Volume Required Per Well
Serum, plasma and other biological fluids (100 uL)
Sensitivity
18.75 pg/mL
Assay Range
31.25-2000 pg/mL
Product Specifications
Assay Type
Sandwich-CLIA
Kit Type
ELISA Kit (Chemiluminescence)
Reactivity
Human
Specificity
This kit recognizes Human BRAK/CXCL14 in samples. No significant cross-reactivity or interference between Human BRAK/CXCL14 and analogues was observed.
Precision
Intra-Assay Precision (Precision within an assay) CV% < 8.27%
Inter-Assay Precision (Precision between assays) CV% < 9.1%
Recovery for Human CXCL14/BRAK ELISA Kit (Chemiluminescence)
Recovery
94-112%
Linearity
Scientific Data Images for Human CXCL14/BRAK ELISA Kit (Chemiluminescence)
ELISA: Human CXCL14/BRAK ELISA Kit (Chemiluminescence) [NBP2-70018] -
ELISA: Human CXCL14/BRAK ELISA Kit (Chemiluminescence) [NBP2-70018] - Standard Curve ReferenceKit Contents for Human CXCL14/BRAK ELISA Kit (Chemiluminescence)
- Biotinylated Detection Ab Diluent
- Concentrated Biotinylated Detection Ab (100x)
- Concentrated HRP Conjugate (100x)
- Concentrated Wash Buffer (25x)
- HRP Conjugate Diluent
- Micro CLIA Plate (Dismountable)
- Plate Sealer
- Product Manual
- Reference Standard
- Sample Diluent
- Substrate Reagent A
- Substrate Reagent B
Preparation and Storage
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Storage of components varies. See protocol for specific instructions.
Background: CXCL14/BRAK
Alternate Names
Bolekine, BRAK, CXC-X3
Gene Symbol
CXCL14
Additional CXCL14/BRAK Products
Product Documents for Human CXCL14/BRAK ELISA Kit (Chemiluminescence)
Product Specific Notices for Human CXCL14/BRAK ELISA Kit (Chemiluminescence)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. ELISA Kits are guaranteed for 6 months from date of receipt.
Loading...
Loading...
Loading...
Loading...